{"id":"https://openalex.org/W2013279548","doi":"https://doi.org/10.1021/jm0101343","title":"Three-Dimensional Quantitative Structure\u2212Activity Relationships of Cyclo-oxygenase-2 (COX-2) Inhibitors: A Comparative Molecular Field Analysis","display_name":"Three-Dimensional Quantitative Structure\u2212Activity Relationships of Cyclo-oxygenase-2 (COX-2) Inhibitors: A Comparative Molecular Field Analysis","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W2013279548","doi":"https://doi.org/10.1021/jm0101343","mag":"2013279548","pmid":"https://pubmed.ncbi.nlm.nih.gov/11563921"},"language":"en","primary_location":{"id":"doi:10.1021/jm0101343","doi":"https://doi.org/10.1021/jm0101343","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0101343","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037261246","display_name":"Philippe Chavatte","orcid":"https://orcid.org/0000-0001-9620-7564","observed_orcids":["https://orcid.org/0000-0001-9620-7564"]},"institutions":[{"id":"https://openalex.org/I12449238","display_name":"Universit\u00e9 d'Orl\u00e9ans","ror":"https://ror.org/014zrew76","country_code":"FR","type":"education","lineage":["https://openalex.org/I12449238"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210141565","display_name":"Institut de Chimie Organique et Analytique","ror":"https://ror.org/03ywn7d79","country_code":"FR","type":"facility","lineage":["https://openalex.org/I12449238","https://openalex.org/I1294671590","https://openalex.org/I2738703131","https://openalex.org/I4210128300","https://openalex.org/I4210141565"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Philippe Chavatte","raw_affiliation_strings":["Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France","institution_ids":["https://openalex.org/I12449238","https://openalex.org/I2279609970","https://openalex.org/I4210141565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017495421","display_name":"Sa\u0131\u0308d Yous","orcid":"https://orcid.org/0000-0001-9221-6535","observed_orcids":["https://orcid.org/0000-0001-9221-6535"]},"institutions":[{"id":"https://openalex.org/I12449238","display_name":"Universit\u00e9 d'Orl\u00e9ans","ror":"https://ror.org/014zrew76","country_code":"FR","type":"education","lineage":["https://openalex.org/I12449238"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210141565","display_name":"Institut de Chimie Organique et Analytique","ror":"https://ror.org/03ywn7d79","country_code":"FR","type":"facility","lineage":["https://openalex.org/I12449238","https://openalex.org/I1294671590","https://openalex.org/I2738703131","https://openalex.org/I4210128300","https://openalex.org/I4210141565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sa\u00efd Yous","raw_affiliation_strings":["Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France","institution_ids":["https://openalex.org/I12449238","https://openalex.org/I2279609970","https://openalex.org/I4210141565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091021808","display_name":"Christophe Marot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12449238","display_name":"Universit\u00e9 d'Orl\u00e9ans","ror":"https://ror.org/014zrew76","country_code":"FR","type":"education","lineage":["https://openalex.org/I12449238"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210141565","display_name":"Institut de Chimie Organique et Analytique","ror":"https://ror.org/03ywn7d79","country_code":"FR","type":"facility","lineage":["https://openalex.org/I12449238","https://openalex.org/I1294671590","https://openalex.org/I2738703131","https://openalex.org/I4210128300","https://openalex.org/I4210141565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Marot","raw_affiliation_strings":["Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France","institution_ids":["https://openalex.org/I12449238","https://openalex.org/I2279609970","https://openalex.org/I4210141565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036757314","display_name":"Nicolas Baurin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12449238","display_name":"Universit\u00e9 d'Orl\u00e9ans","ror":"https://ror.org/014zrew76","country_code":"FR","type":"education","lineage":["https://openalex.org/I12449238"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210141565","display_name":"Institut de Chimie Organique et Analytique","ror":"https://ror.org/03ywn7d79","country_code":"FR","type":"facility","lineage":["https://openalex.org/I12449238","https://openalex.org/I1294671590","https://openalex.org/I2738703131","https://openalex.org/I4210128300","https://openalex.org/I4210141565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Baurin","raw_affiliation_strings":["Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France","institution_ids":["https://openalex.org/I12449238","https://openalex.org/I2279609970","https://openalex.org/I4210141565"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035522540","display_name":"Daniel Lesieur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12449238","display_name":"Universit\u00e9 d'Orl\u00e9ans","ror":"https://ror.org/014zrew76","country_code":"FR","type":"education","lineage":["https://openalex.org/I12449238"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I4210141565","display_name":"Institut de Chimie Organique et Analytique","ror":"https://ror.org/03ywn7d79","country_code":"FR","type":"facility","lineage":["https://openalex.org/I12449238","https://openalex.org/I1294671590","https://openalex.org/I2738703131","https://openalex.org/I4210128300","https://openalex.org/I4210141565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Daniel Lesieur","raw_affiliation_strings":["Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Chimie Pharmaceutique Albert Lespagnol, Universit\u00e9 de Lille 2, BP 83, F-59006 Lille C\u00e9dex, France, and Institut de Chimie Organique et Analytique, UMR 6005, Universit\u00e9 d'Orl\u00e9ans, BP 6759, F-45067 Orl\u00e9ans C\u00e9dex 2, France","institution_ids":["https://openalex.org/I12449238","https://openalex.org/I2279609970","https://openalex.org/I4210141565"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5037261246"],"corresponding_institution_ids":["https://openalex.org/I12449238","https://openalex.org/I2279609970","https://openalex.org/I4210141565"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":6.7158,"has_fulltext":false,"cited_by_count":111,"citation_normalized_percentile":{"value":0.98191409,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"44","issue":"20","first_page":"3223","last_page":"3230"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/cox-2-selective-inhibitors","display_name":"COX-2 selective inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/3d-qsar","display_name":"3D-QSAR","score":0.8989999890327454},{"id":"https://openalex.org/keywords/comfa","display_name":"CoMFA","score":0.9430000185966492},{"id":"https://openalex.org/keywords/anti-inflammatory-drug-design","display_name":"anti-inflammatory drug design","score":0.8289999961853027},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8450948596000671},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.6694519519805908},{"id":"https://openalex.org/C201194858","wikidata":"https://www.wikidata.org/wiki/Q898238","display_name":"Steric effects","level":2,"score":0.6260898113250732},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.620195746421814},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.596859335899353},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.48011136054992676},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3686251938343048},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18435516953468323},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D001555","descriptor_name":"Benzene Derivatives","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003517","descriptor_name":"Cyclopentanes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013141","descriptor_name":"Spiro Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm0101343","doi":"https://doi.org/10.1021/jm0101343","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm0101343","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:11563921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11563921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1494920110","https://openalex.org/W1968431776","https://openalex.org/W1975058685","https://openalex.org/W1982273085","https://openalex.org/W1996975778","https://openalex.org/W2000724113","https://openalex.org/W2007248773","https://openalex.org/W2018488725","https://openalex.org/W2030850720","https://openalex.org/W2033498682","https://openalex.org/W2052080593","https://openalex.org/W2055280453","https://openalex.org/W2057124385","https://openalex.org/W2063060349","https://openalex.org/W2081649582","https://openalex.org/W2093154530","https://openalex.org/W2117227343","https://openalex.org/W2161239029","https://openalex.org/W2327667256","https://openalex.org/W2625545845","https://openalex.org/W4296367864"],"related_works":["https://openalex.org/W2057124385","https://openalex.org/W2883664407","https://openalex.org/W2393344436","https://openalex.org/W2405370693","https://openalex.org/W2080569138","https://openalex.org/W2558769074","https://openalex.org/W2117432256","https://openalex.org/W2370793635","https://openalex.org/W2362412588","https://openalex.org/W7097262080"],"abstract_inverted_index":{"The":[0,76,119],"three-dimensional":[1],"quantitative":[2],"structure-activity":[3],"relationship":[4],"(3D-QSAR)":[5],"approach":[6],"using":[7],"comparative":[8],"molecular":[9],"field":[10],"analysis":[11],"(CoMFA)":[12],"was":[13,41,98],"applied":[14],"to":[15,43,158],"an":[16],"extensive":[17],"series":[18],"of":[19,32,49,103,122,133,145],"305":[20],"varied":[21],"diarylheterocyclic":[22],"derivatives":[23],"known":[24],"as":[25],"COX-2":[26,33,39,126],"selective":[27,38],"inhibitors.":[28,51],"X-ray":[29],"crystal":[30],"structure":[31],"bound":[34],"with":[35,69,115,124],"SC-558,":[36],"a":[37,142],"inhibitor,":[40],"used":[42],"derive":[44],"the":[45,59,70,104,116,125,130],"putative":[46],"bioactive":[47],"conformation":[48],"these":[50],"Five":[52],"statistically":[53],"significant":[54],"models":[55],"were":[56],"obtained":[57,108],"from":[58],"randomly":[60],"constituted":[61],"training":[62],"sets":[63,73],"(229":[64],"compounds)":[65],"and":[66,112,147],"subsequently":[67],"validated":[68],"corresponding":[71],"test":[72],"(76":[74],"compounds).":[75],"best":[77],"predictive":[78],"model":[79,135],"(n":[80],"=":[81,84,87,90,93,96],"229,":[82],"q(2)":[83],"0.714,":[85],"N":[86],"8,":[88],"r(2)":[89],"0.905,":[91],"s":[92],"0.291,":[94],"F":[95],"261.545)":[97],"selected":[99],"for":[100,109,141],"further":[101],"comparison":[102],"CoMFA":[105],"contour":[106],"maps":[107],"steric,":[110],"electrostatic,":[111],"lipophilic":[113],"fields":[114],"enzyme":[117,127],"structure.":[118],"high":[120],"level":[121],"compatibility":[123],"topology":[128],"shows":[129],"great":[131],"accuracy":[132],"this":[134],"that":[136],"can":[137],"predict":[138],"inhibitory":[139],"activities":[140],"wide":[143],"range":[144],"compounds":[146],"offers":[148],"important":[149],"structural":[150],"insight":[151],"into":[152],"designing":[153],"novel":[154],"antiinflammatory":[155],"drugs":[156],"prior":[157],"their":[159],"synthesis.":[160]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}